Key Stock Ideas: F&O, Zydus Lifesciences, TPG, - ARETE Securities
NSE to roll back 6% transaction charges on equity and F&O trading from April 1:
The board of National Stock Exchange (NSE) on March 24 stated that it has decided to rolled back the 6 percent increase in transaction charges on equity cash and derivatives segment, with effect from April 1.In January 2021, the charges were increased by 6 percent partly, to augment the investor corpus in view of certain market exigencies due to broker defaults.
Zydus Recalls Over 55,000 Bottles Of Generic Drug In U.S:
Drug firm Zydus Lifesciences is recalling over 55,000 bottles of generic medication in the U.S. market due to failed impurities specifications. As per the latest enforcement report by the U.S. Food and Drug Administration, Zydus Pharmaceuticals (USA) Inc is recalling 21,936 (30 count) and 33,096 (100 count) bottles of Colchicine tablets, which are used to treat gout. The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the U.S. by New Jersey-based Zydus Pharmaceuticals Inc. USFDA said the company is recalling the product due to "failed impurities/ degradation specifications".
TPG Sells 7.6% Stake In Campus Activewear For Rs 806 Crore:
Private equity firm TPG on Friday divested 7.6% stake in sports and athleisure footwear company, Campus Activewear, for Rs 806 crore through an open market transaction. TPG, through its affiliate TPG Growth III SF Pte, offloaded the shares in Campus Activewear.According to the bulk deal data available on the National Stock Exchange (NSE), TPG Growth III SF Pte sold 2,32,07,692 shares, amounting to a 7.62% stake in the firm. The shares were disposed of at an average price of Rs 347.24 apiece, taking the transaction value to Rs 805.86 crore. As of December 2022, TPG Growth III SF Pte owned a 7.62% stake in the firm.
RBI may opt for 25 bps interest rate hike in monetary policy meet: Experts
With retail inflation remaining above the comfort level of 6 per cent and most global peers including US Fed continuing hawkish stance, the Reserve Bank of India too may go in for a 25 basis points hike in the bi-monthly monetary policy to be announced on April 6, opined experts.In its last policy meeting held in February, RBI had raised the policy rate or repo by 25 basis points to 6.50 per cent.
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer at http://www.aretesecurities.com/
SEBI Regn. No.: INM000012740
Above views are of the author and not of the website kindly read disclaimer
Tag News
The Markets are expected to open higher today as trend in SGX nifty - ARETE Securities